• The Avicenna Alliance discussed upcoming activities

    The Avicenna Alliance board was convened by Secretary General Thierry Marchal on 23 March where board members around the world discussed the activities of the Alliance.

    FIND OUT MORE

  • Avicenna Alliance founding Sec Gen leaves legacy of policy success

    As the Avicenna Alliance enters its 3rd year of operation in 2018, it brings with it a change in management and a huge upscaling of activities.

    FIND OUT MORE

  • Avicenna Alliance continues to grow by welcoming Cipla among its members

    The latest company to join Avicenna Alliance is the pharmaceutical company Cipla.

    FIND OUT MORE

Resignation of FDA Commissioner Gottlieb – a note of Marco Viceconti

We have read this morning that Scott Gottlieb, US Food and Drug Administration Commissioner, will leave the job at the end of the...

find out more ›

Avicenna Alliance continues to grow by welcoming VCLS among its members

The Avicenna Alliance is happy to welcome its newest member: Voisin Consulting Life Sciences.

find out more ›

The Council of the European Union adopted conclusions on AI

The Council of the European Union – under the Competitiveness formation, gathering the Ministers of the Member States – adopted conclusions...

find out more ›

In silico method mentioned in JRC report on alternatives to animal testing

On 7 February, the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) - which is an...

find out more ›

Artificial Intelligence and clinical research: which issues remain?

This issue is discussed in the new article written under the direction of Vincent Diebolt, Director of the French Clinical Research...

find out more ›

FEops  joins Avicenna Alliance

As further evidence of the Alliance’s growing momentum, Avicenna Alliance is happy to announce the newest addition to our list of members: FEops.

find out more ›

Commission participates  to international In Silico Toxicology Protocol initiative

The European Commission’s Joint Research Center (JRC) Directorate published on 22 November an article highlighting...

find out more ›